281 related articles for article (PubMed ID: 19101513)
21. Oligodendrocytes are susceptible to apoptotic cell death induced by prion protein-derived peptides.
Sponne I; Fifre A; Koziel V; Kriem B; Oster T; Olivier JL; Pillot T
Glia; 2004 Jul; 47(1):1-8. PubMed ID: 15139007
[TBL] [Abstract][Full Text] [Related]
22. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
[TBL] [Abstract][Full Text] [Related]
23. Prions: protein aggregation and infectious diseases.
Aguzzi A; Calella AM
Physiol Rev; 2009 Oct; 89(4):1105-52. PubMed ID: 19789378
[TBL] [Abstract][Full Text] [Related]
24. Strategies for eliminating PrP(c) as substrate for prion conversion and for enhancing PrP(Sc) degradation.
Gilch S; Nunziante M; Ertmer A; Schätzl HM
Vet Microbiol; 2007 Aug; 123(4):377-86. PubMed ID: 17493775
[TBL] [Abstract][Full Text] [Related]
25. Prion proteins: physiological functions and role in neurological disorders.
Hu W; Kieseier B; Frohman E; Eagar TN; Rosenberg RN; Hartung HP; Stüve O
J Neurol Sci; 2008 Jan; 264(1-2):1-8. PubMed ID: 17707411
[TBL] [Abstract][Full Text] [Related]
26. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
Sasaki K; Minaki H; Iwaki T
J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
[TBL] [Abstract][Full Text] [Related]
27. Neuroendocrine cultured cells counteract persistent prion infection by down-regulation of PrPc.
Aguib Y; Gilch S; Krammer C; Ertmer A; Groschup MH; Schätzl HM
Mol Cell Neurosci; 2008 May; 38(1):98-109. PubMed ID: 18387818
[TBL] [Abstract][Full Text] [Related]
28. Evidence for prion protein expression in enteroglial cells of the myenteric plexus of mouse intestine.
Albanese V; Lawson VA; Hill AF; Cappai R; Di Guardo G; Staikopoulos V; Thacker M; Furness JB; Chiocchetti R
Auton Neurosci; 2008 Jun; 140(1-2):17-23. PubMed ID: 18358791
[TBL] [Abstract][Full Text] [Related]
29. Unraveling the details of prion (con)formation(s): recent advances by mass spectrometry.
Principe S; Maras B; Schininà ME; Pocchiari M; Cardone F
Curr Opin Drug Discov Devel; 2008 Sep; 11(5):697-707. PubMed ID: 18729021
[TBL] [Abstract][Full Text] [Related]
30. CREB-dependent gene regulation by prion protein: impact on MMP-9 and beta-dystroglycan.
Pradines E; Loubet D; Schneider B; Launay JM; Kellermann O; Mouillet-Richard S
Cell Signal; 2008 Nov; 20(11):2050-8. PubMed ID: 18718863
[TBL] [Abstract][Full Text] [Related]
31. Neurotoxic species in prion disease: a role for PrP isoforms?
Harrison CF; Barnham KJ; Hill AF
J Neurochem; 2007 Dec; 103(5):1709-20. PubMed ID: 17944867
[TBL] [Abstract][Full Text] [Related]
32. Cellular prion protein is implicated in the regulation of local Ca2+ movements in cerebellar granule neurons.
Lazzari C; Peggion C; Stella R; Massimino ML; Lim D; Bertoli A; Sorgato MC
J Neurochem; 2011 Mar; 116(5):881-90. PubMed ID: 21214552
[TBL] [Abstract][Full Text] [Related]
33. Activation of phosphatidylinositol 3-kinase by cellular prion protein and its role in cell survival.
Vassallo N; Herms J; Behrens C; Krebs B; Saeki K; Onodera T; Windl O; Kretzschmar HA
Biochem Biophys Res Commun; 2005 Jun; 332(1):75-82. PubMed ID: 15896301
[TBL] [Abstract][Full Text] [Related]
34. Cellular prion protein expression in astrocytes modulates neuronal survival and differentiation.
Lima FR; Arantes CP; Muras AG; Nomizo R; Brentani RR; Martins VR
J Neurochem; 2007 Dec; 103(6):2164-76. PubMed ID: 17868300
[TBL] [Abstract][Full Text] [Related]
35. [Functions of prion protein PrPc].
Cazaubon S; Viegas P; Couraud PO
Med Sci (Paris); 2007; 23(8-9):741-5. PubMed ID: 17875293
[TBL] [Abstract][Full Text] [Related]
36. Interaction between the cellular prion (PrPC) and the 2P domain K+ channel TREK-1 protein.
Azzalin A; Ferrara V; Arias A; Cerri S; Avella D; Pisu MB; Nano R; Bernocchi G; Ferretti L; Comincini S
Biochem Biophys Res Commun; 2006 Jul; 346(1):108-15. PubMed ID: 16750514
[TBL] [Abstract][Full Text] [Related]
37. Prion protein affects Ca2+-activated K+ currents in cerebellar purkinje cells.
Herms JW; Tings T; Dunker S; Kretzschmar HA
Neurobiol Dis; 2001 Apr; 8(2):324-30. PubMed ID: 11300727
[TBL] [Abstract][Full Text] [Related]
38. Understanding the neurospecificity of Prion protein signaling.
Schneider B; Pietri M; Pradines E; Loubet D; Launay JM; Kellermann O; Mouillet-Richard S
Front Biosci (Landmark Ed); 2011 Jan; 16(1):169-86. PubMed ID: 21196165
[TBL] [Abstract][Full Text] [Related]
39. Physiopathologic implications of the structural and functional domains of the prion protein.
Sorgato MC; Bertoli A
Ital J Biochem; 2006; 55(3-4):222-31. PubMed ID: 17274528
[TBL] [Abstract][Full Text] [Related]
40. [Molecular genetics of familial and sporadic forms of human prion diseases].
Laplanche JL; Launay JM; Dreux C
Ann Pharm Fr; 1995; 53(5):193-200. PubMed ID: 7503507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
